Papers
2
Total Citations
47
H-Index
2
About
Dr. Sang Cheol Lee is a urologic oncologist whose research focuses on improving outcomes for prostate cancer patients, particularly through predictive modeling and the role of sarcopenia. His work centers on two key areas: enhancing post-surgical quality of life and refining prognostic tools for cancer recurrence. Dr. Lee’s most impactful contribution is the development and validation of nomograms to predict the recovery of urinary continence after radical prostatectomy. This 2013 study, cited 45 times, provides clinicians with a practical tool to counsel patients on their likely continence trajectory—immediate, early, or late—thereby managing expectations and guiding rehabilitation. More recently, Dr. Lee has explored the influence of pre-operative muscle mass on cancer outcomes. His 2021 multi-center study investigates how the internal obturator muscle mass index, measured via MRI, relates to biochemical recurrence following surgery. By linking sarcopenia to prostate cancer prognosis, this work opens new avenues for pre-operative risk stratification and potential interventions. Dr. Lee’s research bridges surgical technique with patient-centered metrics, offering both immediate clinical utility and a forward-looking perspective on how body composition affects cancer survival.
Research Focus
Key Achievements
Top Papers
- 1
- 2